Email
Print
Biosimilars And Follow-On Biologics Market - Forecast(2024 - 2030)
1. Biosimilars And Follow-On Biologics Market - Overview
1.1 Definitions and Scope
2. Biosimilars And Follow-On Biologics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biosimilars And Follow-On Biologics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biosimilars And Follow-On Biologics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biosimilars And Follow-On Biologics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biosimilars And Follow-On Biologics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biosimilars And Follow-On Biologics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biosimilars And Follow-On Biologics Market - By Manufacturing (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 In-House Manufacturing
8.3.2 Contract Manufacturing Organization
9. Biosimilars And Follow-On Biologics Market - By Product (Market Size -$Million / $Billion)
1.1 Definitions and Scope
2. Biosimilars And Follow-On Biologics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biosimilars And Follow-On Biologics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biosimilars And Follow-On Biologics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biosimilars And Follow-On Biologics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biosimilars And Follow-On Biologics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biosimilars And Follow-On Biologics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biosimilars And Follow-On Biologics Market - By Manufacturing (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Segment Analysis
8.3.1 In-House Manufacturing
8.3.2 Contract Manufacturing Organization
9. Biosimilars And Follow-On Biologics Market - By Product (Market Size -$Million / $Billion)
9.1 Erythropoetin
9.2 Granulocyte-colony Stimulating Factor
9.3 Growth Hormone
9.4 Alfa Interferon
9.5 Beta Interferon
9.6 Monoclonal ANtibody
9.7 Follitropin
10. Biosimilars And Follow-On Biologics - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Blood Disorder
10.3.2 Cancer
10.3.3 Chronic And Autoimmune Disease
10.3.4 Growth Hormone Deficiency
11. Biosimilars And Follow-On Biologics- By Geography (Market Size -$Million / $Billion)
11.1 Biosimilars And Follow-On Biologics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biosimilars And Follow-On Biologics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biosimilars And Follow-On Biologics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biosimilars And Follow-On Biologics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong Kong
11.8.5.9 Rest of APAC
11.9 Biosimilars And Follow-On Biologics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biosimilars And Follow-On Biologics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilars And Follow-On Biologics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biosimilars And Follow-On Biologics Market - Key Company List by Country Premium
15. Biosimilars And Follow-On Biologics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Biocon Limited
15.3 Cadila Pharmaceutical
15.4 Dr. Reddys Laboratory Limited
15.5 F. Hoffmann-La Roche Ag
15.6 Intas Pharmaceutical Limited
15.7 Lupin Limited
15.8 Reliance Life Science Private Limited
15.9 Sanofi S A
15.10 Torrent Pharmaceutical Ltd
15.11 Wockhardt Limited
15.12 Company 11
15.13 Company 12 & More
16.1 Abbreviations
16.2 Sources
17. Biosimilars And Follow-On Biologics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
10. Biosimilars And Follow-On Biologics - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Blood Disorder
10.3.2 Cancer
10.3.3 Chronic And Autoimmune Disease
10.3.4 Growth Hormone Deficiency
11. Biosimilars And Follow-On Biologics- By Geography (Market Size -$Million / $Billion)
11.1 Biosimilars And Follow-On Biologics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biosimilars And Follow-On Biologics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biosimilars And Follow-On Biologics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biosimilars And Follow-On Biologics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong Kong
11.8.5.9 Rest of APAC
11.9 Biosimilars And Follow-On Biologics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biosimilars And Follow-On Biologics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilars And Follow-On Biologics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biosimilars And Follow-On Biologics Market - Key Company List by Country Premium
15. Biosimilars And Follow-On Biologics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Biocon Limited
15.3 Cadila Pharmaceutical
15.4 Dr. Reddys Laboratory Limited
15.5 F. Hoffmann-La Roche Ag
15.6 Intas Pharmaceutical Limited
15.7 Lupin Limited
15.8 Reliance Life Science Private Limited
15.9 Sanofi S A
15.10 Torrent Pharmaceutical Ltd
15.11 Wockhardt Limited
15.12 Company 11
15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Biosimilars And Follow-On Biologics Market - Appendix16.1 Abbreviations
16.2 Sources
17. Biosimilars And Follow-On Biologics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)1.1 Erythropoetin Market 2023-2030 ($M) - Global Industry Research
1.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Global Industry Research
1.3 Growth Hormone Market 2023-2030 ($M) - Global Industry Research
1.4 Alfa Interferon Market 2023-2030 ($M) - Global Industry Research
1.5 Beta Interferon Market 2023-2030 ($M) - Global Industry Research
1.6 Monoclonal Antibody Market 2023-2030 ($M) - Global Industry Research
1.7 Follitropin Market 2023-2030 ($M) - Global Industry Research
2.Global India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
2.1 In-House Manufacturing Market 2023-2030 ($M) - Global Industry Research
2.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Global Industry Research
3.Global India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 (Volume/Units)
3.1 Erythropoetin Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Growth Hormone Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Alfa Interferon Market 2023-2030 (Volume/Units) - Global Industry Research
3.5 Beta Interferon Market 2023-2030 (Volume/Units) - Global Industry Research
3.6 Monoclonal Antibody Market 2023-2030 (Volume/Units) - Global Industry Research
3.7 Follitropin Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 (Volume/Units)
4.1 In-House Manufacturing Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Contract Manufacturing Organization Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
5.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
5.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
5.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
5.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
5.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
5.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
5.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
6.North America India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
6.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
6.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
7.South America India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
7.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
7.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
7.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
7.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
7.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
7.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
7.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
8.South America India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
8.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
8.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
9.Europe India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
9.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
9.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
9.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
9.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
9.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
9.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
9.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
10.Europe India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
10.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
10.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
11.APAC India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
11.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
11.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
11.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
11.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
11.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
11.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
11.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
12.APAC India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
12.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
12.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
13.MENA India Biosimilars Follow-On Biologics Market, By Product Market 2023-2030 ($M)
13.1 Erythropoetin Market 2023-2030 ($M) - Regional Industry Research
13.2 Granulocyte-Colony Stimulating Factor Market 2023-2030 ($M) - Regional Industry Research
13.3 Growth Hormone Market 2023-2030 ($M) - Regional Industry Research
13.4 Alfa Interferon Market 2023-2030 ($M) - Regional Industry Research
13.5 Beta Interferon Market 2023-2030 ($M) - Regional Industry Research
13.6 Monoclonal Antibody Market 2023-2030 ($M) - Regional Industry Research
13.7 Follitropin Market 2023-2030 ($M) - Regional Industry Research
14.MENA India Biosimilars Follow-On Biologics Market, By Type Of Manufacturing Market 2023-2030 ($M)
14.1 In-House Manufacturing Market 2023-2030 ($M) - Regional Industry Research
14.2 Contract Manufacturing Organization Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)2.Canada India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
3.Mexico India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
4.Brazil India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
5.Argentina India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
6.Peru India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
7.Colombia India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
8.Chile India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
9.Rest of South America India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
10.UK India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
11.Germany India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
12.France India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
13.Italy India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
14.Spain India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
15.Rest of Europe India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
16.China India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
17.India India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
18.Japan India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
19.South Korea India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
20.South Africa India Biosimilars And Follow-On Biologics Market Revenue, 2023-2030 ($M)
21.North America India Biosimilars And Follow-On Biologics By Application
22.South America India Biosimilars And Follow-On Biologics By Application
23.Europe India Biosimilars And Follow-On Biologics By Application
24.APAC India Biosimilars And Follow-On Biologics By Application
25.MENA India Biosimilars And Follow-On Biologics By Application
26.Cadila Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Lupin Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Torrent Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Wockhardt Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Reliance Life Science Private Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Intas Pharmaceutical Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Dr. Reddys Laboratory Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Biocon Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)